Gapping up
In reaction to earnings/guidance:
- GPRO +18.7%, GLUU +15.3%, COTY +15%, TTD +12.3%, NET +11.3%, UI +11%, IRWD +10.2%, INSG +9.6%, CNDT +9.2%, ZG +8.9%, HUBS +8%, IAC +7.7% (also IAC's Vimeo announces $150 mln equity investment from Thrive Capital and GIC), HLF +7.2% (also names new CFO; declares distribution of warrants; also Icahn entered into Letter Agreement with respect to support agreement), YELP +6.8%, MD +6.8%, APPN +6.4%, GKOS +6.2%, UFS +5.9%, LASR +5.8%, DISH +5.5%, ENDP +5.3%, TSE +5.1%, EVBG +5.1%, AAXN +5.1%, TMUS +5.1%, ROKU +5%, SQ +4.3%, COLL +3.8%, MTSI +3.8%, GOLF +3.8%, SSP +3.6%, ATGE +3.4%, CUBE +3.2%, TTWO +3.2%, DLX +3.2%, PFSI +3.1%, SPCE +3.1%, RUN +2.9%, NWSA +2.9%, NTRA +2.8%, MBUU +2.8%, NKTR +2.7%, CVS +2.7%, TPIC +2.6%, IRTC +2.5%, PRAA +2.4%, VIRT +2.4%, HSY +2.2%, BGS +2%, ESNT +2%, AINV +1.9%, TU +1.9%, TDS +1.6%, USM +1.6%, COLD +1.6%, HMC +1.6%, AMN +1.5%, SYNA +1.5%, ALTR +1.4%, EDIT +1.4%, AMRX +1.4%, CARG +1.2%, HMSY +1.2%, AVLR +1.1% (also acquires the operational assets of Business Licenses), MGA +1.1%, VIAV +1%
Other news:
- FTCH +11.4% (FTCH enters into partnership with BABA and Richemont)
- FBNC +8.6% (to be added to S&P SmallCap 600)
- HALO +7.8% (to be added to S&P MidCap 400)
- HGEN +7.2% (announces positive interim Phase 3 Data of Lenzilumab in patients hospitalized with COVID-19; also announces cooperative research and development agreement with the Department of Defense to develop lenzilumab for COVID-19)
- MD +6.8% (to be added to S&P SmallCap 600)
- MTG +6.2% (to be added to S&P MidCap 400)
- PROG +5.7% (announces encouraging preclinical data supporting the potential of the company's oral drug delivery system in targeting the colon)
- TFFP +4.1% (files for $100 mln mixed securities shelf offering; also files for 4.0 mln share offering by selling shareholder; also TFFP and Felix Biotech enter into a LOI to enter into a collaboration/license agreement)
- RUN +2.9% (to expand Brightbox offering to all active markets; also stock offering)
- GEO +2% (to be added to S&P SmallCap 600)
- UVV +2% (approves $100 mln stock repurchase program)
- EVH +1.3% (to provide oncology services to Florida Blue Medicare)
- XRX +1.2% (Carl Icahn boosts active stake and discloses purchase of more than 1 mln shares)
- AVTR +1.1% (prices secondary offering by certain of its stockholders of 71,569,765 shares of common stock at $25.25 per share)
- UNIT +1% (announces dismissal of litigation)
Analyst comments:
- TX +2.7% (upgraded to Overweight from Neutral at JP Morgan)
- IFRX +2.4% (upgraded to Outperform from Mkt Perform at SVB Leerink)
- TREE +2.2% (upgraded to Overweight from Neutral at JP Morgan)